| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |